Jenster G - Search Results

1

Immuno-based detection of extracellular vesicles in urine as diagnostic marker for prostate cancer.

Duijvesz D, Versluis CY, van der Fels CA, Vredenbregt-van den Berg MS, Leivo J, Peltola MT, Bangma CH, Pettersson KS, Jenster G. Duijvesz D, et al. Among authors: jenster g. Int J Cancer. 2015 Dec 15;137(12):2869-78. doi: 10.1002/ijc.29664. Epub 2015 Jul 16. Int J Cancer. 2015. PMID: 26139298 Free article.

2

Androgen receptor modifications in prostate cancer cells upon long-termandrogen ablation and antiandrogen treatment.

Marques RB, Erkens-Schulze S, de Ridder CM, Hermans KG, Waltering K, Visakorpi T, Trapman J, Romijn JC, van Weerden WM, Jenster G. Marques RB, et al. Among authors: jenster g. Int J Cancer. 2005 Nov 1;117(2):221-9. doi: 10.1002/ijc.21201. Int J Cancer. 2005. PMID: 15900601 Free article.

3

The human PC346 xenograft and cell line panel: a model system for prostate cancer progression.

Marques RB, van Weerden WM, Erkens-Schulze S, de Ridder CM, Bangma CH, Trapman J, Jenster G. Marques RB, et al. Among authors: jenster g. Eur Urol. 2006 Feb;49(2):245-57. doi: 10.1016/j.eururo.2005.12.035. Epub 2006 Jan 6. Eur Urol. 2006. PMID: 16413664 Review.

4

Bladder carcinogenesis, in search of clues and genes.

Bangma C, Jenster G. Bangma C, et al. Among authors: jenster g. Eur Urol. 2006 Aug;50(2):205-7. doi: 10.1016/j.eururo.2006.02.019. Epub 2006 Feb 28. Eur Urol. 2006. PMID: 16530924 No abstract available.

5

Evolution of the androgen receptor pathway during progression of prostate cancer.

Hendriksen PJ, Dits NF, Kokame K, Veldhoven A, van Weerden WM, Bangma CH, Trapman J, Jenster G. Hendriksen PJ, et al. Among authors: jenster g. Cancer Res. 2006 May 15;66(10):5012-20. doi: 10.1158/0008-5472.CAN-05-3082. Cancer Res. 2006. PMID: 16707422 Free article.

6

Truncated ETV1, fused to novel tissue-specific genes, and full-length ETV1 in prostate cancer.

Hermans KG, van der Korput HA, van Marion R, van de Wijngaart DJ, Ziel-van der Made A, Dits NF, Boormans JL, van der Kwast TH, van Dekken H, Bangma CH, Korsten H, Kraaij R, Jenster G, Trapman J. Hermans KG, et al. Among authors: jenster g. Cancer Res. 2008 Sep 15;68(18):7541-9. doi: 10.1158/0008-5472.CAN-07-5930. Cancer Res. 2008. PMID: 18794142

7

Screening for prostate cancer in 2008 II: the importance of molecular subforms of prostate-specific antigen and tissue kallikreins.

Jansen FH, Roobol M, Jenster G, Schröder FH, Bangma CH. Jansen FH, et al. Among authors: jenster g. Eur Urol. 2009 Mar;55(3):563-74. doi: 10.1016/j.eururo.2008.11.040. Epub 2008 Nov 29. Eur Urol. 2009. PMID: 19058905 Review.

8

Overexpression of prostate-specific TMPRSS2(exon 0)-ERG fusion transcripts corresponds with favorable prognosis of prostate cancer.

Hermans KG, Boormans JL, Gasi D, van Leenders GJ, Jenster G, Verhagen PC, Trapman J. Hermans KG, et al. Among authors: jenster g. Clin Cancer Res. 2009 Oct 15;15(20):6398-403. doi: 10.1158/1078-0432.CCR-09-1176. Epub 2009 Oct 13. Clin Cancer Res. 2009. PMID: 19825963

9

Differential expression of protease activity in serum samples of prostate carcinoma patients with metastases.

Dekker LJ, Burgers PC, Charif H, van Rijswijk AL, Titulaer MK, Jenster G, Bischoff R, Bangma CH, Luider TM. Dekker LJ, et al. Among authors: jenster g. Proteomics. 2010 Jun;10(12):2348-58. doi: 10.1002/pmic.200900682. Proteomics. 2010. PMID: 20394078

10

Exosomes as biomarker treasure chests for prostate cancer.

Duijvesz D, Luider T, Bangma CH, Jenster G. Duijvesz D, et al. Among authors: jenster g. Eur Urol. 2011 May;59(5):823-31. doi: 10.1016/j.eururo.2010.12.031. Epub 2010 Dec 29. Eur Urol. 2011. PMID: 21196075 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

201 results

Search Page